Investors
Please Read Before ContinuingExcept for the historical information set forth in this Web site and within its content, matters set forth in this Web site and within its content, including but not limited to statements relating to our drug discovery efforts, preclinical and clinical development programs and drug candidates, and any statements relating to ACADIA's goals, plans, missions, expectations, beliefs, and the like, are forward-looking statements within the meaning of the "safe harbor" provisions of the Private Securities Litigation Reform Act of 1995. These forward-looking statements are subject to risks and uncertainties that may cause actual results to differ materially, including the risks and uncertainties inherent in the discovery, development and commercialization of drugs, the risks and uncertainties associated with our technologies and those of our competitors, and other risks detailed in our annual report on Form 10-K as well as other subsequent filings made from time to time with the Securities and Exchange Commission, which are available at www.sec.gov. These forward-looking statements speak only as of the date of the development or update of this Web site. ACADIA's disclaims any intent or obligation to update these forward-looking statements.
back to top